Canopy Biosciences LLC has acquired Core Diagnostics, a provider of biomarker analysis services for biopharmaceutical researchers. No financial terms were disclosed. Canopy Biosciences is backed by ...

Core Laboratories is the premier provider of reservoir characterization services. Its foundational core analysis business has been virtually untouched over the last several decades, and the firm has ...

Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) announced better-than-expected revenue in Q3 CY2025, but sales fell by 3.7% year on year to $699.9 million. The company expects the full year’s ...

On Jan 18, we issued an updated research report on Quest Diagnostics, Inc.DGX. The stock carries a Zacks Rank #3 (Hold). We are optimistic about Quest Diagnostics' consistent efforts to refocus on ...

Diagnostic chain Metropolis Healthcare on Monday said it will acquire Core Diagnostics for Rs 247 crore. The company's board has approved the acquisition of 100 per cent stake in Core Diagnostics from ...

Marc Stapley, CEO of Veracyte, discusses the importance of ongoing evidence collection. Marc Stapley: There’s been a lot of change in diagnostics in general, but particularly in oncology over the last ...

ST. LOUIS, Dec. 4, 2019 /PRNewswire/ -- Canopy Biosciences, LLC announced today the acquisition of Core Diagnostics, a leading CLIA-certified provider of biomarker analysis services for ...